INVO Fertility (IVF) Current Deferred Revenue (2018 - 2026)
INVO Fertility's (IVF) quarterly Current Deferred Revenue came in at $725493.0 in Q1 2026, little changed year-on-year from $725330.0 in Q1 2025, and little changed on a QoQ basis from $721897.0 in Q4 2025.
INVO Fertility (IVF) Current Deferred Revenue (2018 - 2026) Analysis & Trends
INVO Fertility (IVF) has 9 years of Current Deferred Revenue data on file, last reported at $725493.0 in Q1 2026.
- On a quarterly basis, Current Deferred Revenue changed 0.02% year-over-year to $725493.0 in Q1 2026; TTM through Mar 2026 was $725493.0, a 0.02% change from a year earlier, with the FY2025 full-year figure at $721897.0, up 19.84% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $725493.0, roughly flat from $721897.0 in the prior quarter.
- Over the last five years, Current Deferred Revenue for IVF reached as high as $834850.0 in Q2 2025 and fell as low as $5793.0 in Q1 2022.
- Historically, Current Deferred Revenue has averaged $410071.5 across 5 years, with a median of $416745.0 in 2024.
- On a YoY basis, Current Deferred Revenue climbed as much as 1931.8% in 2022 and fell as far as 99.83% in 2022.
- Year by year, Current Deferred Revenue stood at $119876.0 in 2022, then surged by 240.99% to $408769.0 in 2023, then surged by 47.36% to $602359.0 in 2024, then grew by 19.84% to $721897.0 in 2025, then increased by 0.5% to $725493.0 in 2026.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $725493.0 in Q1 2026, $721897.0 in Q4 2025, and $720407.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | INVO Fertility | 1,108.74 | -4.90 Mn | 732,978.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 725,493.00 |
| Dec 31, 2025 | 721,897.00 |
| Sep 30, 2025 | 720,407.00 |
| Jun 30, 2025 | 834,850.00 |
| Mar 31, 2025 | 725,330.00 |
| Dec 31, 2024 | 602,359.00 |
| Sep 30, 2024 | 562,402.00 |
| Jun 30, 2024 | 416,745.00 |
| Mar 31, 2024 | 513,425.00 |
| Dec 31, 2023 | 408,769.00 |
| Sep 30, 2023 | 229,921.00 |
| Jun 30, 2023 | 161,187.00 |
| Mar 31, 2023 | 46,746.00 |
| Dec 31, 2022 | 119,876.00 |
| Sep 30, 2022 | 98,659.00 |
| Jun 30, 2022 | 77,357.00 |
| Mar 31, 2022 | 5,793.00 |
| Dec 31, 2021 | 5,900.00 |
| Sep 30, 2021 | 714,286.00 |
| Jun 30, 2021 | 714,286.00 |